Recent patents on experimental therapy for hepatitis C virus infection (1999 – 2002)

Author： Hoffmann Per   Quasdorff Maria   González-Carmona Maria Á   Caselmann Wolfgang H  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.11, 2003-11, pp. : 1707-1723

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Experimental and emerging therapies for chronic hepatitis C virus infection

By Zein Nizar N  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 8, 2001-08 ,pp. : 1457-1469

Informa Healthcare

Access to resources Recommend Favorite

Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus

By Foster Graham R  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 685-691

Informa Healthcare

Access to resources Recommend Favorite

The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection

By  

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 2081-2092

Bentham Science Publishers

Access to resources Recommend Favorite

Therapy of Chronic Hepatitis C Virus Infection in HIV Co-Infected People

By  

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 2111-2122

Bentham Science Publishers

Access to resources Recommend Favorite

Developments in hepatitis C therapy during 2000 – 2002

By Poordad F Fred   Tran Tram   Martin Paul  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 9-25

Informa Healthcare

Access to resources Recommend Favorite